Evidence map›Paper›PMID 41673186›Full record

ArticleCommunications medicine2026

Asymptomatic school-age children carry the majority of transmissible Plasmodium falciparum infections.

Andrea G Buchwald, Jimmy Vareta, Otutochukwu Nwagbata, Robert S McCann, Alick Sixpence, Alfred Matengeni, Moses Kamzati, Charles Mangani, Karl B Seydel, Mark L Wilson and 5 more

Abstract read
In one paragraph

Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Serological evidence of high exposure toMalariaWorld journal · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andrea G BuchwaldCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. abuchwald@som.umaryland.edu.ORCID http://orcid.org/0000-0001-6503-6459
Jimmy VaretaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-5421-9433
Otutochukwu NwagbataUniversity of Maryland School of Medicine, Baltimore, MD, USA.
Robert S McCannCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-2195-6461
Alick SixpenceMalaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi.
Alfred MatengeniMalaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi.
Moses KamzatiMalaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi.
Charles ManganiMalaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi.
Karl B SeydelBlantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.
Mark L WilsonDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0003-2968-5181
Terrie E TaylorCollege of Osteopathic Medicine, Michigan State University, East Lansing, MI, USA.ORCID http://orcid.org/0000-0001-7416-3986
Don P MathangaMalaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi.
Clarissa ValimBoston University School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9621-203X
Miriam K LauferCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-8300-9593
Lauren M CoheeCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-7575-630X

Funding

Dissecting the causal impact of prenatal HIV exposure and the postnatal environment on development in Malawian InfantsK01MH134741 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI BUCHWALD, ANDREA G. · 2023 to 2025
$468k
NIMH NIH HHS K01 MH134741U.S. Department of Health & Human Services | National Institutes of Health (NIH) K01MD134741
6 · The paper itself

Abstract

backgroundPersistent human-to-mosquito parasite transmission hinders malaria control in high burden settings. Understanding the human transmission reservoir can support the design of targeted interventions to reduce transmission.

methodsIn a year-long cohort study in rural Malawi, we used molecular methods to detect all Plasmodium falciparum (Pf) infections and those containing gametocytes, the parasite stage required for transmission, longitudinally at routine surveillance and sick visits. Using population-level analyses, we determined the demographic, temporal, and spatial clustering of infections containing gametocytes and gametocyte density, which predicts transmission.

resultsHere we show that gametocytes are not randomly distributed among the population or among individuals with Pf infections; gametocytes are detected in only 23% of the population. Among all participants, school-age children have significantly higher incidence of gametocyte-containing infections and high-density gametocyte infections compared to other groups. The presence of school-age children is a key driver of gametocyte frequencies and densities within households, even after adjusting for Pf infection levels. Based on the total gametocyte abundance in the population, we estimate that clearing infections from asymptomatic school-age children in the rainy season would decrease gametocyte abundance by 67% in the population.

conclusionsSchool-age children are the primary driver of ongoing Pf transmission in Malawi and interventions targeting school-age children are needed to effectively reduce Pf infection risk at a population level.

Identifiers

PMID41673186
PMCPMC13005036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.